POSSIBILITIES OF FORECASTING EARLY PREECLAMPSIA IN 11-13 WEEK OF GESTATION

Author: Belotserkovtseva L.D.¹, Kovalenko L.V.², Telitsyn D.P.³

Abstract

The purpose of the study was to study the levels of placental growth factor (PlGF) and soluble receptor-1 vascular endothelial growth factor (sVEGF-R1) in the mother’s serum during normal pregnancy and pre-eclampsia developed before 34 weeks of pregnancy in the period 11–13 weeks. Material and methods. In a prospective study, 95 patients were selected on the basis of risk factors for the development of pre-eclampsia in the first prenatal screen and further examined blood for PlGF and sVEGF-R1. According to the results of the course of pregnancy, the patients were divided into 4 groups: the first group – preeclampsia developed before the 34th week of pregnancy, the 2nd group – uncomplicated pregnancy, the 3rd group – pregnancy proceeding with fetoplacental insufficiency, the 4th group – pregnancy ending in preterm labor. Results and discussion. In women with preeclampsia that developed before the 34th week of gestation, the medians of sVEGF and PlGF were 2275 and 64.5 pg/ml, respectively, in pregnancy with placental insufficiency – 648.9 and 31.5 pg/ml, in pregnancy ending in preterm labor – 102.5 and 20 pg/ml, in uncomplicated pregnancy – 1170.0 and 34,5 pg/ml. The results can be used in the screening of the first trimester of pregnancy to predict various pathological conditions of pregnancy.

Key words

early preeclampsia, preterm labor, placental insufficiency, placental growth factor, soluble receptor-1 vascular endothelial factor

References

Belotserkovtseva L.D., Kovalenko L.V., Telitsyn D.P. Retrospective analysis of early preeclampsia in the Surgut clinical perinatal center. Vestnik SurGU. Meditsina = Bulletin of SurGU. Medicine. 2017. (4). 17-21. [In Russian].

Carmeliet P. Angiogenesis in health and disease // Nat. Med. 2003. 9. 653–660.

Filippov O.S., Guseva E.V., Malyshkina A.I., Mikhailov A.V., Linde V.A., Zubenko N.V., Fatkullin I.F., Bashmakova N.V., Artymuk N.V., Pestrikova T.Yu. Maternal mortality in the Russian Federation in 2015. Methodical letter of the Ministry of Health of the Russian Federation No. 15-4 / 10 / 2-6810 of 10.28.2016. 85s. [In Russian].

Fillipov O.S, Guseva E.V., Sidorova I.S., Nikitina N.A. Maternal mortality in the Russian Federation: analysis of official data and the results of a confidential audit in 2013. Methodical letter of the Ministry of Health of the Russian Federation No. 15-4/10/2-7509 of 02.10.2014. 91 p. [In Russian].

Fong G.H., Rossant J., Gertsentein M., Breitman M.L. Role of the Flt-1 tyrosine kinase in regulating the assembly of vascular endothelium // Nature. 1995. 376. 66–70.

Hiratsuka S., Minova O., Kuno J., Noda T., Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice // Proc. Natl. Acad. Sci. USA. 1998. 95. 9349–9354.

Kvehaugen A.S., Dechend R., Ramstad H.B., Troisi R., Fugelseth D., Staff A.C. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia // Hypertension. 2011. 58. (1). 63-9.

Ogge G., Chaiworapongsa T., Romero R., Hussein Y., Kusanovic J.P., Yeo L., Kim C.J., Hassan S.S. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia // J. Perinat. Med. 2011. 39. (6). 641-52.

Redman C.W., Sargent I.L., Staft A.C. IFPA Senior award lecture: making sense of pre-eclampsia – two placental causes of preeclampsia // Placenta. 2014. 35. s20-s25.

Shcherbakov V.I., Pozdnyakov I.M., Shirinskaya A.V., Volkov M.V. The level of interleukin-6, soluble receptors of interleukin-6 and vascular endothelial growth factor during urgent labor, the threat of preterm birth and preeclampsia. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2017. (3). 50-54. [In Russian].

Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis // Cell Struct. Funct. 2001. 26. 25–35

Staff A.C. Circulating predictive biomarkers in preeclampsia // Pregnancy Hypertens. 2011. 1. (1). 28-42.

Stevens W., Shih T., Incerti D., Ton T.G.N., Lee H.C., Peneva D., Macones G.A., Sibai B.M., Jena A.B. Short-term costs of preeclampsia to the United States health care system // Am. J. Obstet. Gynecol. 2017. 217. (3). 237-248.

Tsatsaris V., Muller F., Maillard F., Delattre M., Guibourdenche J., Dreux S., Winer N., Brion D.E., Goffinet F. OS039. Early prediction of preeclampsia with maternal parameters, SVEGF-R1, PLGF, Inhibin-A and PAPP-A in general population: Results from the MSPE study // Pregnancy Hypertens. 2. (3). 197–198.

About Authors (Correspondence):

Telitsyn D.P. – postgraduate student of the department of obstetrics and gynecology, e-mail: telicyndenis@gmail.com

Full Text

snmzh_2-2019_belocerkovceva_81-85.pdf

Received: 24/04/2019

Accepted: 24/04/2019